HomeALOPM • EPA
add
Oncodesign Precision Medicine Opm SA
Previous close
€0.36
Day range
€0.36 - €0.37
Year range
€0.33 - €1.38
Market cap
6.55M EUR
Avg Volume
17.21K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 517.53K | 39.91% |
Operating expense | 765.05K | -18.89% |
Net income | -1.80M | 13.87% |
Net profit margin | -348.74 | 38.44% |
Earnings per share | — | — |
EBITDA | -1.77M | 28.88% |
Effective tax rate | 10.00% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.27M | -48.99% |
Total assets | 10.71M | -35.60% |
Total liabilities | 11.14M | -13.92% |
Total equity | -429.39K | — |
Shares outstanding | 18.17M | — |
Price to book | -18.00 | — |
Return on assets | -43.26% | — |
Return on capital | -64.80% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.80M | 13.87% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Oct 2022
Website
Employees
18
